It is known that HLA-ABC is crucial for proper presentation of specific antigens on the cancer cell surface for recognition by cytotoxic CD8 T cells [62], and that full activation of CD8 T cells requires both expression of HLA-ABC and expression of the T cell costimulatory molecule CD80 or CD86. This evidence concerns the gene CD8A and cancer.